Safety and efficacy of off-label bulevirtide monotherapy in patients with HDV with decompensated Child-B cirrhosis—A real-world case seriesChristopher Dietz-Fricke, Pietro Lampertico, Florian P. Reiter et al.|Hepatology|2024Cited by 36
LB01 SIX WEEKS OF SOFOSBUVIR/LEDIPASVIR TREATMENT OF ACUTE HEPATITIS C VIRUS GENOTYPE 1 MONOINFECTION: FINAL RESULTS OF THE THE GERMAN HEPNET ACUTE HCV IV STUDYKatja Deterding, Maurizio Degiuli, Christoph D. Spinner et al.|United European Gastroenterology Journal|2016Cited by 5